Mechanism of HES1 regulating herceptin resistance in gastric cancer cells by ferroptosis
10.16438/j.0513-4870.2023-0420
- VernacularTitle:HES1通过铁死亡调控胃癌细胞对赫赛汀耐药的机制研究
- Author:
Jin-hua ZHANG
1
;
Jin-xia CHANG
2
;
Jian-cai TANG
2
;
Wen-hu LIU
1
Author Information
1. Department of Pharmacy, North Sichuan Medical College, Nanchong 637100, China; Innovation Centre for Science and Technology, Nanchong 637100, China
2. School of Basic Medical Sciences and Forensic Medical, North Sichuan Medical College, Nanchong 637100, China
- Publication Type:Research Article
- Keywords:
hairy and enhancer of SPLIT1;
herceptin;
resistance;
proteomics;
ferroptosis;
TP53/SLC7A11/GPX4
- From:
Acta Pharmaceutica Sinica
2023;58(11):3354-3365
- CountryChina
- Language:Chinese
-
Abstract:
Drug resistance of cancer cells is the main causes of chemotherapy failure, and gene mutation or function loss is key factor to induce drug resistance. Previous studies have shown that hairy and enhancer of split 1 (HES1) is up-regulated in herceptin-resistant gastric cancer cells, and inhibition of its activity can reverse its resistance while the potential mechanism has not yet been elucidated. In this study, we employed CRISPR/Cas9 to establish HES1 knock-out cell line (△HES1/NCI N87R) to investigate the functions of HES1 in herceptin resistance of NCI N87R cells and its potential mechanisms. We investigated proteomics profiling of △HES1/NCI N87R cells based on quantitative proteomics. Gene ontology analysis was conducted by GeneSet Enrichment Analysis (GSEA) and Metascape database, and pathway enrichment analysis was done using GeneAnalytics database. The selected molecules were quantified by Western blot and some pathways were verified by using inhibitors. The results showed that the resistance to herceptin of △HES1/NCI N87R cells decreased compared to NCI N87R cells. Proteomic data demonstrated that the expression of 1 263 genes changed significantly in △HES1/NCI N87R cells, among which 761 genes were up-regulated while 502 ones down-regulated comparing with NCI N87R cells. Pathway analysis showed that ferroptosis, fatty acid β-oxidation, autophagy and glutathione metabolism, etc. exhibited notable changes in △HES1/NCI N87R cells. The functional studies showed that the levels of iron ion and malondialdehyde increased, and glutathione decreased in △HES1/NCI N87R cells. It was further found that Fer-1, a ferroptosis inhibitor, could reverse the expression of pTP53, solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase 4 (GPX4) in △HES1/NCI N87R cell, and reduce the sensitivity of △HES1/NCI N87R cells to herceptin. It is suggested that HES1 regulated the resistance of NCI N87R cells to herceptin through TP53/SLC7A11/GPX4 signaling pathway, and targeting TP53/SLC7A11/GPX4 signal axis mediated by HES1 is a potential strategy to reverse herceptin resistance in gastric cancer.
